Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.

Schwartz SR, Kumwenda N, Kumwenda J, Chen S, Mofenson LM, Taylor AW, Fowler MG, Taha TE.

Matern Child Health J. 2016 Mar;20(3):542-9. doi: 10.1007/s10995-015-1852-5.

2.

Beyond prevention of mother-to-child transmission: keeping HIV-exposed and HIV-positive children healthy and alive.

Kellerman SE, Ahmed S, Feeley-Summerl T, Jay J, Kim M, Phelps BR, Sugandhi N, Schouten E, Tolle M, Tsiouris F; Child Survival Working Group of the Interagency Task Team on the Prevention and Treatment of HIV infection in Pregnant Women, Mothers and Children..

AIDS. 2013 Nov;27 Suppl 2:S225-33. doi: 10.1097/QAD.0000000000000107. Review.

3.

Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.

Fowler MG, Coovadia H, Herron CM, Maldonado Y, Chipato T, Moodley D, Musoke P, Aizire J, Manji K, Stranix-Chibanda L, Fawzi W, Chetty V, Msweli L, Kisenge R, Brown E, Mwatha A, Eshleman SH, Richardson P, Allen M, George K, Andrew P, Zwerski S, Mofenson LM, Jackson JB; HPTN 046 Protocol Team..

J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):366-74. doi: 10.1097/QAI.0000000000000052.

4.

Burden of HIV among primary school children and feasibility of primary school-linked HIV testing in Harare, Zimbabwe: a mixed methods study.

Bandason T, Langhaug LF, Makamba M, Laver S, Hatzold K, Mahere S, Munyati S, Mungofa S, Corbett EL, Ferrand RA.

AIDS Care. 2013;25(12):1520-6. doi: 10.1080/09540121.2013.780120.

5.

Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants.

Fogel JM, Mwatha A, Richardson P, Brown ER, Chipato T, Alexandre M, Moodley D, Elbireer A, Mirochnick M, George K, Mofenson LM, Zwerski S, Coovadia HM, Eshleman SH.

Pediatr Infect Dis J. 2013 Apr;32(4):e164-9. doi: 10.1097/INF.0b013e31827f44ee.

6.

Human milk oligosaccharide concentration and risk of postnatal transmission of HIV through breastfeeding.

Bode L, Kuhn L, Kim HY, Hsiao L, Nissan C, Sinkala M, Kankasa C, Mwiya M, Thea DM, Aldrovandi GM.

Am J Clin Nutr. 2012 Oct;96(4):831-9.

7.

Consideration of postpartum management in HIV-positive Haitian women: an analysis of CD4 decline, mortality, and follow-up after delivery.

Coria A, Noel F, Bonhomme J, Rouzier V, Perodin C, Marcelin A, Li Z, Tosteson TD, Deschamps MM, Wright PF, Pape JW.

J Acquir Immune Defic Syndr. 2012 Dec 15;61(5):636-43. doi: 10.1097/QAI.0b013e31826abdd1.

8.

Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants.

Fogel JM, Taha TE, Sun J, Hoover DR, Parsons TL, Kumwenda JJ, Mofenson LM, Fowler MG, Hendrix CW, Kumwenda NI, Eshleman SH, Mirochnick M.

J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):462-5.

9.

Current knowledge and future research on infant feeding in the context of HIV: basic, clinical, behavioral, and programmatic perspectives.

Young SL, Mbuya MN, Chantry CJ, Geubbels EP, Israel-Ballard K, Cohan D, Vosti SA, Latham MC.

Adv Nutr. 2011 May;2(3):225-43. doi: 10.3945/an.110.000224. Review.

10.

The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV.

Johnson LF, Stinson K, Newell ML, Bland RM, Moultrie H, Davies MA, Rehle TM, Dorrington RE, Sherman GG.

J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):417-25. doi: 10.1097/QAI.0b013e3182432f27.

11.

Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.

Drake AL, Roxby AC, Ongecha-Owuor F, Kiarie J, John-Stewart G, Wald A, Richardson BA, Hitti J, Overbaugh J, Emery S, Farquhar C.

J Infect Dis. 2012 Feb 1;205(3):366-75. doi: 10.1093/infdis/jir766.

12.

Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants.

Fogel J, Li Q, Taha TE, Hoover DR, Kumwenda NI, Mofenson LM, Kumwenda JJ, Fowler MG, Thigpen MC, Eshleman SH.

Clin Infect Dis. 2011 Apr 15;52(8):1069-76. doi: 10.1093/cid/cir008.

13.

Survival and health benefits of breastfeeding versus artificial feeding in infants of HIV-infected women: developing versus developed world.

Kuhn L, Aldrovandi G.

Clin Perinatol. 2010 Dec;37(4):843-62, x. doi: 10.1016/j.clp.2010.08.011. Review.

14.

Correlation of immune activation during late pregnancy and early postpartum with increases in plasma HIV RNA, CD4/CD8 T cells, and serum activation markers.

Truong HM, Sim MS, Dillon M, Uittenbogaart CH, Dickover R, Plaeger SF, Bryson YJ.

Clin Vaccine Immunol. 2010 Dec;17(12):2024-8. doi: 10.1128/CVI.00088-10.

15.

Molecular mechanisms of HIV-1 mother-to-child transmission and infection in neonatal target cells.

Ahmad N.

Life Sci. 2011 May 23;88(21-22):980-6. doi: 10.1016/j.lfs.2010.09.023. Review.

16.

Potential impact of new WHO criteria for antiretroviral treatment for prevention of mother-to- child HIV transmission.

Kuhn L, Aldrovandi GM, Sinkala M, Kankasa C, Mwiya M, Thea DM.

AIDS. 2010 Jun 1;24(9):1374-7.

17.

Lactation-associated postpartum weight changes among HIV-infected women in Zambia.

Murnane PM, Arpadi SM, Sinkala M, Kankasa C, Mwiya M, Kasonde P, Thea DM, Aldrovandi GM, Kuhn L.

Int J Epidemiol. 2010 Oct;39(5):1299-310. doi: 10.1093/ije/dyq065.

18.

Milk mysteries: Why are women who exclusively breast-feed less likely to transmit HIV during breast-feeding?

Kuhn L.

Clin Infect Dis. 2010 Mar 1;50(5):770-2. doi: 10.1086/650536. No abstract available.

Supplemental Content

Support Center